GlassScriptPhysician profile
Heather Peluso
NPI 1285084871
$1,267.85
in general payments reported to CMS, 2019-2025
12 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.15 · 2020: $128 · 2021: $29.65 · 2022: $293 · 2023: $566 · 2024: $67.72 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $341.71 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $223.96 | 2023 | |
| Motiva USA, LLC | $160.50 | 2025 | |
| Medline Industries LP | $143.84 | 2022 | |
| Innovation Technologies INC | $100.00 | 2022 | |
| Boston Scientific Corporation | $93.84 | 2020 | |
| Integra Lifesciences Corporation | $77.37 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $34.34 | 2020 | |
| Radius Health, INC. | $29.65 | 2021 | |
| Axogen | $24.14 | 2022 | |
| Ethicon US, LLC | $23.15 | 2019 | |
| Solventum Corporation | $15.35 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Peluso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.